125 related articles for article (PubMed ID: 37278345)
1. Hydrogen nanobubbles: A novel approach toward radio-sensitization agents.
Hashemi S; Aghamiri SM; Siavashpour Z; Kahani M; Zaidi H; Jaberi R
Med Phys; 2023 Oct; 50(10):6589-6599. PubMed ID: 37278345
[TBL] [Abstract][Full Text] [Related]
2. Gold nanoparticle-based brachytherapy enhancement in choroidal melanoma using a full Monte Carlo model of the human eye.
Asadi S; Vaez-zadeh M; Masoudi SF; Rahmani F; Knaup C; Meigooni AS
J Appl Clin Med Phys; 2015 Sep; 16(5):344–357. PubMed ID: 26699318
[TBL] [Abstract][Full Text] [Related]
3. Investigation of gold nanoparticle effects in brachytherapy by an electron emitter ophthalmic plaque.
Hashemi S; Aghamiri MR; Kahani M; Jaberi R
Int J Nanomedicine; 2019; 14():4157-4165. PubMed ID: 31239674
[No Abstract] [Full Text] [Related]
4. Dose characteristics of Au-198 eye brachytherapy applicator: A Monte Carlo study.
Kamrani S; Aghamiri SMR; Hashemi S
Appl Radiat Isot; 2021 Oct; 176():109866. PubMed ID: 34293507
[TBL] [Abstract][Full Text] [Related]
5. Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS.
Chiu-Tsao ST; Astrahan MA; Finger PT; Followill DS; Meigooni AS; Melhus CS; Mourtada F; Napolitano ME; Nath R; Rivard MJ; Rogers DW; Thomson RM
Med Phys; 2012 Oct; 39(10):6161-84. PubMed ID: 23039655
[TBL] [Abstract][Full Text] [Related]
6. Model-based dose calculations for COMS eye plaque brachytherapy using an anatomically realistic eye phantom.
Lesperance M; Inglis-Whalen M; Thomson RM
Med Phys; 2014 Feb; 41(2):021717. PubMed ID: 24506608
[TBL] [Abstract][Full Text] [Related]
7. Ocular brachytherapy dosimetry for 103Pd and 125I in the presence of gold nanoparticles: a Monte Carlo study.
Asadi S; Vaez-Zadeh M; Vahidian M; Marghchouei M; Masoudi SF
J Appl Clin Med Phys; 2016 May; 17(3):90-99. PubMed ID: 27167265
[TBL] [Abstract][Full Text] [Related]
8. Monte Carlo dosimetry modeling of focused kV x-ray radiotherapy of eye diseases with potential nanoparticle dose enhancement.
Yan H; Ma X; Sun W; Mendez S; Stryker S; Starr-Baier S; Delliturri G; Zhu D; Nath R; Chen Z; Roberts K; MacDonald CA; Liu W
Med Phys; 2018 Oct; 45(10):4720-4733. PubMed ID: 30133705
[TBL] [Abstract][Full Text] [Related]
9. A Monte Carlo dose calculation system for ophthalmic brachytherapy based on a realistic eye model.
Miras Del Río H; Ortiz Lora A; Bertolet Reina A; Terrón León JA
Med Phys; 2021 Aug; 48(8):4542-4559. PubMed ID: 34250607
[TBL] [Abstract][Full Text] [Related]
10. Delivered dose changes in COMS plaque-based ocular brachytherapy arising from vitrectomy with silicone oil replacement.
Morrison H; Larocque MP; Menon G; Sloboda RS; Weis E
Brachytherapy; 2019; 18(5):668-674. PubMed ID: 31272841
[TBL] [Abstract][Full Text] [Related]
11. Accurate estimation of dose distributions inside an eye irradiated with 106Ru plaques.
Brualla L; Sempau J; Zaragoza FJ; Wittig A; Sauerwein W
Strahlenther Onkol; 2013 Jan; 189(1):68-73. PubMed ID: 23161122
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of dose enhancement in presence of gold nanoparticles in eye brachytherapy by
Rezaei H; Zabihzadeh M; Ghorbani M; Goli Ahmadabad F; Mostaghimi H
Australas Phys Eng Sci Med; 2017 Sep; 40(3):545-553. PubMed ID: 28509080
[TBL] [Abstract][Full Text] [Related]
13. Monte Carlo dosimetry of the eye plaque design used at the St. Erik Eye Hospital for (125)I brachytherapy.
Karlsson M; Nilsson J; Lundell M; Carlsson Tedgren A
Brachytherapy; 2014; 13(6):651-6. PubMed ID: 24950821
[TBL] [Abstract][Full Text] [Related]
14. Dosimetry for 125I seed (model 6711) in eye plaques.
Chiu-Tsao ST; Anderson LL; O'Brien K; Stabile L; Liu JC
Med Phys; 1993; 20(2 Pt 1):383-9. PubMed ID: 8497229
[TBL] [Abstract][Full Text] [Related]
15. Comparison between beta radiation dose distribution due to LDR and HDR ocular brachytherapy applicators using GATE Monte Carlo platform.
Mostafa L; Rachid K; Ahmed SM
Phys Med; 2016 Aug; 32(8):1007-18. PubMed ID: 27499370
[TBL] [Abstract][Full Text] [Related]
16. Monte Carlo dosimetry for 103Pd, 125I, and 131Cs ocular brachytherapy with various plaque models using an eye phantom.
Lesperance M; Martinov M; Thomson RM
Med Phys; 2014 Mar; 41(3):031706. PubMed ID: 24593710
[TBL] [Abstract][Full Text] [Related]
17. Individualized dosimetry in Ru-106 ophthalmic brachytherapy based on MRI-derived ocular anatomical parameters.
Liakopoulos DA; Perisinakis K; Solomou G; Kouvidakis A; Drakonaki EE; Bontzos G; Papadaki E; Detorakis ET
Brachytherapy; 2022; 21(6):904-911. PubMed ID: 35995724
[TBL] [Abstract][Full Text] [Related]
18. Estimates of relative beta radiation doses on central and lateral axes of ruthenium/rhodium COB-type plaque used in eye brachytherapy.
De Paiva E
Appl Radiat Isot; 2020 Feb; 156():108991. PubMed ID: 32056686
[TBL] [Abstract][Full Text] [Related]
19. Treatment plan optimization and robustness of
Heilemann G; Fetty L; Dulovits M; Blaickner M; Nesvacil N; Georg D; Dunavoelgyi R
Radiother Oncol; 2017 Apr; 123(1):119-124. PubMed ID: 28185660
[TBL] [Abstract][Full Text] [Related]
20. Advanced Collapsed cone Engine dose calculations in tissue media for COMS eye plaques loaded with I-125 seeds.
Morrison H; Menon G; Larocque MP; van Veelen B; Niatsetski Y; Weis E; Sloboda RS
Med Phys; 2018 Jul; 45(7):3349-3360. PubMed ID: 29729009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
